Meyer JM.

2017;22(S1):14-28.Nonadherence with oral antipsychotics is a common problem for patients with schizophrenia, one that is often underappreciated by clinicians.One approach was to create a new form of AL using smaller nanomolecular particles rather than the micron-sized particles used for maintenance AL injections.1. Aristada is indicated for the treatment of schizophrenia in adults [see Clinical Studies ()].. Aristada Dosage and Administration Recommended Dosage Aristada is only to be administered as an intramuscular injection by a healthcare professional. The approval of this initiation regimen was based on pharmacokinetic studies demonstrating comparable plasma aripiprazole levels to that which would be achieved when using 21 days of oral aripiprazole coverage. 3,4 References . ARISTADA INITIO is not interchangeable with ARISTADA due to differing pharmacokinetic profiles [see Warnings and Precautions ]. Talk to your doctor if you do not feel like you are getting better during your treatment with aripiprazole extended-release injection.This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.Unless your doctor tells you otherwise, continue your normal diet.If you forget to keep an appointment to receive aripiprazole extended-release injection (Abilify Maintena, Aristrada), call your doctor to schedule another appointment as soon as possible.Aripiprazole extended-release injection may cause other side effects. Dr. Meyer is a Psychopharmacology Consultant, California Department of State Hospitals, Sacramento, California; Clinical Professor of Psychiatry, University of California, San Diego, La Jolla, California; and Deputy Editor of Current Psychiatry.1. Read the information carefully and ask your doctor or pharmacist if you have any questions. CNS Spectrums.

Waltham, MA: Alkermes, Inc.; February 2020.

13. Aripiprazole is in a class of medications called atypical antipsychotics. Talk to the doctor who prescribed this medication if you, a family member, or someone you care for has dementia and is receiving aripiprazole lauroxil.

Waltham, MA: Alkermes Inc; 2018 … Converting oral to long acting injectable antipsychotics: a guide for the perplexed. ARISTADA INITIO and ARISTADA are prodrugs of aripiprazole. Injection-site reactions were reported by 4%, 5%, and 2% of patients treated with 441 mg ARISTADA (monthly), 882 mg ARISTADA (monthly), and placebo, respectively. Aripiprazole lauroxil extended-release injection (Abilify Maintena) is also used for the ongoing treatment of people with bipolar I disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Call your doctor if you have any unusual problems while you are receiving this medication.If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration’s (FDA) MedWatch Adverse Event Reporting program online (In case of overdose, call the poison control helpline at 1-800-222-1222. 1. Aripiprazole lauroxil extended-release injection (Abilify Maintena, Aristada, Aristada Initio) is used alone or in combination with other aripiprazole preparations to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions).

You will also need to take aripiprazole tablets or another antipsychotic medication by mouth for the first two weeks right after receiving your first injection of aripiprazole lauroxil extended-release injection (Aristada). You should bring this list with you each time you visit a doctor or if you are admitted to a hospital.

2017;22(S1):14-28. Individual has a diagnosis or schizophrenia; AND II. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer’s website to obtain the Medication Guide.Talk to your doctor about the risks of receiving aripiprazole lauroxil extended-release injection.Aripiprazole lauroxil extended-release injection (Abilify Maintena, Aristada, Aristada Initio) is used alone or in combination with other aripiprazole preparations to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions).